Article
Cardiac & Cardiovascular Systems
Elizabeth Epstein, Stephen Schale, Michela Brambatti, Hyeri You, Paul Hansen, Julia McCain, Jessica Lin, Barry Greenberg
Summary: Transitioning patients to oral diuretics for >= 24 hours prior to discharge following HF hospitalization did not improve 30-day outcomes. These results suggest that this strategy may not be beneficial for all patients hospitalized for worsening HF.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Yumiko Kawakubo Ichihara, Yasuyuki Shiraishi, Shun Kohsaka, Shintaro Nakano, Yuji Nagatomo, Tomohiko Ono, Makoto Takei, Munehisa Sakamoto, Atsushi Mizuno, Mitsunobu Kitamura, Nozomi Niimi, Takashi Kohno, Tsutomu Yoshikawa
Summary: This study found that patients with behavioral precipitant factors (PFs) had a higher risk of heart failure rehospitalization, despite having a lower risk of in-hospital death.
INTERNATIONAL JOURNAL OF CARDIOLOGY
(2023)
Article
Medicine, General & Internal
Charles Faselis, Phillip H. Lam, Samir Patel, Cherinne Arundel, Gerasimos Filippatos, Prakash Deedwania, Michael R. Zile, Samuel Wopperer, Tran Nguyen, Richard M. Allman, Gregg C. Fonarow, Ali Ahmed
Summary: This study found that the prescription of loop diuretics for heart failure patients upon discharge can impact long-term clinical outcomes, with the effects being modified by the level of congestion upon admission. Patients with no congestion, mild-to-moderate congestion, and severe congestion experienced different outcomes.
AMERICAN JOURNAL OF MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Harriette G. C. Van Spall, Tauben Averbuch, Shun Fu Lee, Urun Erbas Oz, Mamas A. Mamas, James Louis Januzzi, Dennis T. Ko
Summary: The LENT index, derived from combining the LE index and NT-proBNP levels, can predict 30-day readmission or death risk for HF patients at discharge. Each incremental increase in the LE index is associated with a 25% higher risk of the primary outcome. A 10-fold increase in NT-proBNP at admission or discharge is linked to a 48-56% higher risk of the primary outcome.
Article
Cardiac & Cardiovascular Systems
Masatoshi Minamisawa, Brian Claggett, Kota Suzuki, Sheila M. Hegde, Amil M. Shah, Akshay S. Desai, Eldrin F. Lewis, Sanjiv J. Shah, Nancy K. Sweitzer, James C. Fang, Inder S. Anand, Eileen O'Meara, Jean-Lucien Rouleau, Bertram Pitt, Marc A. Pfeffer, Scott D. Solomon, Orly Vardeny
Summary: The study revealed that hyper-polypharmacy was associated with an elevated risk of hospitalization for any reason and any serious adverse events in patients with heart failure with preserved ejection fraction, but not significantly associated with mortality.
CIRCULATION-HEART FAILURE
(2021)
Article
Cardiac & Cardiovascular Systems
Anthony P. Carnicelli, Robert Clare, Paul Hofmann, Karen Chiswell, Adam D. DeVore, Sreekanth Vemulapalli, G. Michael Felker, Phil Sarocco, Robert J. Mentz
Summary: WHF events are common in patients with HFrEF and are associated with more advanced disease, leading to higher rates of death and hospitalization.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Respiratory System
Claudia Gulea, Rosita Zakeri, Jennifer K. Quint
Summary: This study compared clinical outcomes and healthcare resource use between patients with chronic obstructive pulmonary disease (COPD) and heart failure (HF) with different ejection fractions. The results showed that patients with COPD and reduced ejection fraction (HFrEF) had a higher risk of HF-specific hospitalization and mortality but a lower risk of acute exacerbation of COPD (AECOPD) compared to those with COPD and preserved ejection fraction (HFpEF).
ANNALS OF THE AMERICAN THORACIC SOCIETY
(2022)
Article
Cardiac & Cardiovascular Systems
Harriette G. C. Van Spall, Ersilia M. DeFilippis, Shun Fu Lee, Urun Erbas Oz, Richard Perez, Jeff S. Healey, Larry A. Allen, Adriaan A. Voors, Dennis T. Ko, Lehana Thabane, Stuart J. Connolly
Summary: The transitional care model reduced all-cause emergency department visits among females but not males following hospitalization for heart failure.
CIRCULATION-HEART FAILURE
(2021)
Article
Cardiac & Cardiovascular Systems
Husam Abdel-Qadir, Felicia Tai, Ruth Croxford, Peter C. Austin, Eitan Amir, Oscar Calvillo-Arguelles, Heather Ross, Douglas S. Lee, Paaladinesh Thavendiranathan
Summary: This study focused on the prognosis of heart failure (HF) in women who developed HF after receiving anthracyclines or trastuzumab for early stage breast cancer. The results showed that patients with cardiotoxic exposure had fewer comorbidities compared to age-matched controls, and those who developed HF after trastuzumab treatment had a better prognosis than HF controls.
CIRCULATION-HEART FAILURE
(2021)
Article
Cardiac & Cardiovascular Systems
Joao Pedro Ferreira, Faiez Zannad, Javed Butler, Gerasimos Filippatos, Stuart Pocock, Tomoko Iwata, Mikhail Sumin, Cordula Zeller, James L. Januzzi, Stefan D. Anker, Milton Packer
Summary: Early treatment with empagliflozin can reduce the risk of hospitalization and cardiovascular death in patients with recent heart failure hospitalization, regardless of the timing of hospitalization. The drug is safe for use in these patients.
JACC-HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Samuel T. Savitz, Alanna M. Chamberlain, Shannon Dunlay, Sheila M. Manemann, Susan A. Weston, Shaheen Kurani, Veronique L. Roger
Summary: Among patients with heart failure (HF), social risk factors (SRFs) are associated with poor outcomes. However, less is known about how co-occurrence of SRFs affect all-cause health care utilization for patients with HF. This study aimed to address this gap using a novel approach to classify co-occurrence of SRFs.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Cardiac & Cardiovascular Systems
Muhammad Shariq Usman, Tariq Jamal Siddiqi, Stefan D. Anker, George L. Bakris, Deepak L. Bhatt, Gerasimos Filippatos, Gregg C. Fonarow, Stephen J. Greene, James L. Januzzi, Muhammad Shahzeb Khan, Mikhail N. Kosiborod, Darren K. McGuire, Ileana L. Pina, Julio Rosenstock, Muthiah Vaduganathan, Subodh Verma, Shelley Zieroth, Javed Butler
Summary: SGLT2 inhibitors can reduce the risk of heart failure events and cardiovascular death in patients with type 2 diabetes, heart failure, and chronic kidney disease, and the effects are consistent in patients with different combinations of these diseases.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Medicine, General & Internal
Sebastian Gobel, Lukas Hobohm, Alexander Desuki, Tommaso Gori, Thomas Muenzel, Rapezzi Claudio, Philip Wenzel, Karsten Keller
Summary: The prevalence of cardiac amyloidosis (CA) in hospitalized heart failure (HF) patients in Germany is 0.1%. CA is associated with younger age, male gender, and higher prevalence of cancer. CA is independently associated with complications and in-hospital mortality, although cancer strongly influences in-hospital mortality.
EUROPEAN JOURNAL OF INTERNAL MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Vishal N. Rao, Robert J. Mentz, Amanda C. Coniglio, Michelle D. Kelsey, Marat Fudim, Gregg C. Fonarow, Roland A. Matsouaka, Adam D. DeVore, Melissa C. Caughey
Summary: Neighborhood socioeconomic status is associated with in-hospital heart failure outcomes. Patients from disadvantaged neighborhoods have a higher in-hospital mortality rate and are younger, more often Black or Hispanic, and have higher comorbidity burden.
CIRCULATION-HEART FAILURE
(2022)
Article
Immunology
Yuan-Pin Hung, Jen-Chieh Lee, Bo-Yang Tsai, Jia-Ling Wu, Hsiao-Chieh Liu, Hsiu-Chuan Liu, Hsiao-Ju Lin, Pei-Jane Tsai, Wen-Chien Ko
Summary: The risk factors of Clostridium difficile-associated diarrhea (CDAD) vary among hospitalized patients with different lengths of hospital stay. Malignancy, prior cephalosporin, and proton pump inhibitor therapy are independent risk factors for CDAD. Intervention strategies for preventing CDAD may need to be tailored based on the duration of hospital stay.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
(2021)
Editorial Material
Cardiac & Cardiovascular Systems
Paul Heidenreich, Alexander Sandhu
Letter
Cardiac & Cardiovascular Systems
Alexander T. Sandhu, Jimmy Zheng, Megan Skye, Paul A. Heidenreich
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES
(2023)
Article
Cardiac & Cardiovascular Systems
Cati Brown-Johnson, Jamie Calma, Alexis Amano, Marcy Winget, Sonia R. Harris, Stacie Vilendrer, Steve M. Asch, Paul Heidenreich, Alexander T. Sandhu, Neil M. Kalwani
Summary: This study evaluated clinician perceptions of the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) and found that it enhanced multiple aspects of heart failure patient care. Most clinicians reported that the KCCQ-12 was acceptable, appropriate, and useful in clinical care. To promote further implementation, efforts should focus on clinician engagement, streamline electronic health record integration, and provide staff education.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES
(2023)
Article
Cardiac & Cardiovascular Systems
Jimmy Zheng, Paul A. Heidenreich, Shun Kohsaka, William F. Fearon, Alexander T. Sandhu
Summary: CAD testing remains underutilized in patients with newly diagnosed HF. Early CAD evaluation in patients with incident HF is associated with improved clinical management and long-term outcomes, including reduced all-cause mortality.
CIRCULATION-HEART FAILURE
(2023)
Letter
Endocrinology & Metabolism
Robert J. Gallo, Daniel Z. Fang, Paul A. Heidenreich
Review
Cardiac & Cardiovascular Systems
Jimmy Zheng, Thomas Mednick, Paula. Heidenreich, Alexander T. Sandhu
Summary: This study aimed to investigate the associations of nonphysician provider-led guideline-directed medical therapy (GDMT) interventions with therapy use and clinical outcomes. The findings showed that pharmacist- and nurse-led interventions improved guideline concordance and increased the initiation and uptitration of therapies. Further research is needed to evaluate newer therapies and titration strategies integrated with pharmacist and/or nurse-based care.
JOURNAL OF CARDIAC FAILURE
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Aradhana Verma, Paul A. Heidenreich, Boback Ziaeian
JACC-HEART FAILURE
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Dhruv S. Kazi, Paul Heidenreich
JACC-HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Jacob B. Pierce, Muthiah Vaduganathan, Gregg C. Fonarow, Uchechukwu Ikeaba, Karen Chiswell, Javed Butler, Adam D. DeVore, Paul A. Heidenreich, Joanna C. Huang, Michelle M. Kittleson, Karen E. Joynt Maddox, Karthik K. Linganathan, James J. McDermott, Anjali Tiku Owens, Pamela N. Peterson, Scott D. Solomon, Orly Vardeny, Clyde W. Yancy, Stephen J. Greene
Summary: The use of SGLT2 inhibitors (SGLT2i) for patients with heart failure with reduced ejection fraction (HFrEF) is recommended by clinical guidelines. However, the adoption of SGLT2i in the US is unknown. This study found that the prescription rate of SGLT2i for eligible HFrEF patients in the US is low, with significant variation among hospitals.
Article
Cardiac & Cardiovascular Systems
Neil Keshvani, Sonia Shah, Iyanuoluwa Ayodele, Karen Chiswell, Brooke Alhanti, Larry A. Allen, Stephen J. Greene, Clyde W. Yancy, Windy W. Alonso, Harriette G. C. Van Spall, Gregg C. Fonarow, Paul A. Heidenreich, Ambarish Pandey
Summary: Sex differences in long-term outcomes following hospitalization for heart failure (HF) were evaluated in this study. The findings showed that females had a higher risk of rehospitalization compared to males after 5 years of follow-up.
EUROPEAN JOURNAL OF HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Biykem Bozkurt, Tariq Ahmad, Kevin M. Alexander, William L. Baker, Kelly Bosak, Khadijah Breathett, Gregg C. Fonarow, Paul Heidenreich, Jennifer E. Ho, Eileen Hsich, Nasrien E. Ibrahim, Lenette M. Jones, Sadiya S. Khan, Prateeti Khazanie, Todd Koelling, Harlan M. Krumholz, Kiran K. Khush, Christopher Lee, Alanna A. Morris, Robert L. Page, Ambarish Pandey, Mariann R. Piano, Josef Stehlik, Lynne Warner Stevenson, John R. Teerlink, Muthiah Vaduganathan, Boback Ziaeian
JOURNAL OF CARDIAC FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Celina M. M. Yong, Laura Graham, Tariku J. J. Beyene, Shirin Sadri, Juliette Hong, Tom Burdon, William F. F. Fearon, Steven M. M. Asch, Mintu Turakhia, Paul Heidenreich
Summary: During the COVID-19 pandemic, cardiovascular procedural treatments for NSTEMI patients were deferred, with uncertain impact on patient outcomes.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Cardiac & Cardiovascular Systems
Rishi V. Parikh, Alan S. Go, Ankeet S. Bhatt, Thida C. Tan, Amanda R. Allen, Kent Y. Feng, Steven A. Hamilton, Andrew S. Tai, Jesse K. Fitzpatrick, Keane K. Lee, Sirtaz Adatya, Harshith R. Avula, Dana R. Sax, Xian Shen, Joaquim Cristino, Alexander T. Sandhu, Paul A. Heidenreich, Andrew P. Ambrosy
Summary: The study developed predictive models based on electronic health records for worsening heart failure events across different left ventricular ejection fraction categories. Despite differences in underlying heart failure causes, the performance and predictors of the models were found to be similar across various categories.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Paul A. Heidenreich, John J. V. Mcmurray
JACC-HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Neal Yuan, Grant Duffy, Sanket S. Dhruva, Adam Oesterle, Cara N. Pellegrini, John Theurer, Marzieh Vali, Paul A. Heidenreich, Salomeh Keyhani, David Ouyang
Summary: Deep learning applied to outpatient ECGs in sinus rhythm can predict the occurrence of atrial fibrillation in a large and diverse patient population.